ASB Consultores’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-576
Closed -$87.8K 199
2024
Q1
$87.8K Buy
+576
New +$95.8K 0.02% 290
2023
Q3
Sell
-447
Closed -$194K 143
2023
Q2
$194K Buy
447
+93
+26% +$52.3K 0.09% 178
2023
Q1
$210K Buy
+354
New +$198K 0.08% 174

Other funds holding AGL

ASB Consultores's AGL Position: Q2 2024 in Review

ASB Consultores sold out of Agilon Health (AGL) in Q2 2024, closing a stake of 576 shares — an estimated $87.8K sold.

ASB Consultores first reported a position in AGL in Q1 2023 and held it in 3 quarters. The position peaked at $210K in Q1 2023. 201 funds tracked by Wall St. Rank hold AGL as of Q2 2024.

  • ASB Consultores reported no remaining Agilon Health position as of Q2 2024 after selling out during the quarter.
  • ASB Consultores sold 576 Agilon Health shares in Q2 2024, an estimated $87.8K.
  • ASB Consultores first reported a position in Agilon Health in Q1 2023 and held it in 3 quarters.
  • ASB Consultores's Agilon Health position peaked at $210K in Q1 2023.
  • 201 funds tracked by Wall St. Rank held Agilon Health as of Q2 2024.

Based on ASB Consultores's 13F filing for Q2 2024, filed 12 Aug 2024.